Afamelanotide (MT-1) Lyophilized Powder: Enhancing Pain-Free Light Exposure

Discover the science behind afamelanotide and its role in improving light tolerance for EPP patients.

Get a Quote & Sample

Key Advantages

Enhanced Photoprotection

The activation of MC1R by synthetic peptide afamelanotide promotes melanogenesis, leading to increased melanin in the skin, which acts as a natural shield against UV radiation.

Improved Light Tolerance

For patients with EPP, afamelanotide significantly increases the duration of pain-free exposure to sunlight, enhancing their quality of life by reducing photosensitivity.

Research-Grade Purity

Available as a high-purity lyophilized powder, afamelanotide mt-1 lyophilized powder is suitable for advanced research and development in pharmaceutical and dermatological applications.

Key Applications

EPP Treatment Development

Clinical research focuses on using afamelanotide to manage the severe light sensitivity associated with Erythropoietic Protoporphyria, aiming to improve patient outcomes.

Photoprotection Research

Investigating the peptide's ability to protect skin from UV damage by stimulating melanin, a crucial factor in reducing DNA damage and oxidative stress.

Dermatological Studies

Exploring potential benefits for various skin-related conditions by leveraging afamelanotide's influence on melanogenesis and skin repair mechanisms.

Peptide Synthesis and Analysis

Utilizing afamelanotide cas 75921-69-6 in laboratory settings for research into peptide synthesis, characterization, and interaction studies.